openPR Logo
Press release

Heparin Market Size & Analysis - Forecasts to 2026

Heparin Market

Heparin Market

As per the research conducted by GME, the Heparin Market will grow with a CAGR value of 6.5 percent by 2026. Rising healthcare costs and patient recognition standards, augmenting occurrence and mortality correlated with coagulation & chronic disorders, as well as the commodification of effective and cost-effective heparin drugs are presumed to drive growth in the heparin market globally.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Heparin Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-heparin-market-3156

By Type (Low Molecular Weight and Ultra-Low Molecule Weight), By Route Of Administration (Intravenous and Subcutaneous), By Application Form (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, and Others), By End-Use (Inpatients and Outpatients), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis.
Key Market Insights
• Anticoagulant demand is presumed to augment growth in the overall heparin market.
• The low molecular weight is leading in the type segment because companies are actively producing novel technologies.
• Due to the lower costs correlated with hospitalization, the subcutaneous is expected to lead the in the route of administration segment.
• Owing to the growing intensity and occurrence of heart-related diseases, coronary artery disease is presumed to be the market leader.
• Outpatients are likely to predominate in the end-use segment because the outpatient care costs are lower than inpatient hospital costs.
• The market for North America is foreseen to be the predominant, as the country has supportive reimbursement facilities for instruments and devices.
• GlaxoSmithKline plc; Pfizer, Inc.; Baxter; Leo Pharma A/S; Sanofi; Dr. Reddy’s Laboratories Ltd.; Aspen Holdings; B. Braun Medical Inc.; Fresenius SE & Co. KGaA; Teva Pharmaceutical Industries Ltd., Opocrin S.p.A., Bioiberica S.A.U., Fresenius SE & Co. KGaA, Hebei Changshan Biochemical Pharmaceutical Co., Ltd., are the top players in the heparin market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-heparin-market-3156

Type Outlook (Revenue, USD Billion, 2021-2026)
• Low Molecular Weight
• Ultra-Low Molecule Weight

Route Of Administration Outlook (Revenue, USD Billion, 2021-2026)
• Intravenous
• Subcutaneous

Application Outlook (Revenue, USD Billion, 2021-2026)
• Venous Thromboembolism
• Atrial Fibrillation
• Renal Impairment
• Coronary Artery Disease
• Others

End-Use Outlook (Revenue, USD Billion, 2021-2026)
• Inpatients
• Outpatients

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heparin Market Size & Analysis - Forecasts to 2026 here

News-ID: 2287478 • Views: 249

More Releases from Global Market Estimates Research & Consultants

Vital Signs Monitoring Devices Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Vital Signs Monitoring Devices Market is projected to grow from USD 4.7 billion in 2022 to USD 7.9 billion by 2027 at a CAGR value of 6.8% from 2022 to 2027. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Vital Signs Monitoring Devices Market - Forecast to
Traditional Wound Management Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Traditional Wound Management Market is projected to grow from USD 5.9 billion in 2022 to USD 7.1 billion by 2027 at a CAGR value of 3.9% from 2022 to 2027. Smith & Nephew, Mölnlycke Health Care AB, Johnson & Johnson Pvt. Ltd., Derma Sciences Inc., Paul Hartmann AG, B.Braun Melsungen AG, BSN Medical, Medline Industries, Inc.,
Advanced Surgical Navigation Software Market
According to a new market research report published by Global Market Estimates, the Global Advanced Surgical Navigation Software Market is projected to grow at a CAGR value of 6.7%. Stryker, Olympus America, 7D Surgical, Koninklijke Philips N.V., Stratovan Corporation, X-Nav Technologies, Globus Medical, 3D Systems, Inc., RSIP Vision, Novarad, Acclarent, Inc., Pixee Medical, EOS Imaging, Paritic, Holosurgical Inc., Insight Medical Systems, Medtronic Inc., GE Healthcare, B. Braun Melsungen, HipXpert, cortEXplore
HPV Testing and PAP Test Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global HPV Testing and PAP Test is projected to grow from USD 4.01 billion in 2021 to reach 5.20 billion in 2026 with a CAGR value of 7.1% from 2021 to 2026. The market will grow rapidly owing to an increasing number of cervical cancer cases and rising ageing population, as well as increasing awareness of cancer

All 5 Releases


More Releases for Heparin

Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Re …
"The Report Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report studies Heparin(Heparin Sodium and Heparin Calcium) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report
10-11-2017 | Health & Medicine
TMR
Heparin Market – Global Industry Analysis 2016
The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.   “A focus on the expansion of R&D activities, in-licensing
Heparin Market: Professional and Technical Industry Insights
Global Heparin Market: Key Trends  The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions
07-18-2017 | Health & Medicine
Heparin
2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe B …
Researchmoz added Most up-to-date research on "2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin" to its huge collection of research reports. This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning
04-05-2017 | Health & Medicine
TMR
Heparin Market Trend and Outlook to 2023
Heparin is an anticoagulant that is primarily used to prevent and treat venous thrombosis, pulmonary embolism, and other conditions of blood clotting. This report provides in-depth analysis of the global heparin market. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market. The global heparin market has been studied from two perspectives: by products and by geography.